參考文獻(xiàn)/References:
[1] WONG R M Y,WONG P Y,LIU C,et al.The imminent risk of a fracture-existing worldwide data:a systematic review and meta-analysis[J].Osteoporos Int,2022,33(12):2453-2466.
[2] 肖峰,陳俊如,朱旭梅,等.基于骨折聯(lián)絡(luò)服務(wù)的再骨折預(yù)防研究現(xiàn)況[J].現(xiàn)代醫(yī)藥衛(wèi)生,2019,35(8):1182-1184.
[3] SUZUKI N,ARAI K,KON S,et al.Challenges to prevent secondary fractures in patients with hip fractures in Joetsu Myoko,Japan through the increased use of osteoporosis treatment and collaboration with family doctors[J].J Bone Miner Metab,2017,35(3):315-323.
[4] BACHOUR F,RIZKALLAH M,SEBAALY A,et al.Fracture liaison service:report on the first successful experience from the Middle East[J].Arch Osteoporos,2017,12(1):79.
[5] 中華中醫(yī)藥學(xué)會(huì).骨質(zhì)疏松性骨折中醫(yī)診療指南[J].中醫(yī)正骨,2023,35(1):1-9.
[6] 朱赤,高峰.老年骨質(zhì)疏松性脊柱骨折微創(chuàng)術(shù)后患者再發(fā)骨折的危險(xiǎn)因素[J].吉林醫(yī)學(xué),2022,43(12):3246-3249.
[7] 農(nóng)華鋒.骨質(zhì)疏松骨折后再骨折的臨床風(fēng)險(xiǎn)因素[J].世界最新醫(yī)學(xué)信息文摘,2019,19(54):103.
[8] LOUREN?O B C,AMORIM-BARBOSA T,LEMOS C,et al.Risk factors for refracture after proximal femur fragility fracture[J].Porto Biomed J,2023,8(2):e207.
[9] 顧銳.骨質(zhì)疏松性椎體骨折后再骨折的相關(guān)因素分析[D].南京:南京中醫(yī)藥大學(xué),2022.
[10] 肖林燕,馮林美,何朝珠.骨質(zhì)疏松性椎體壓縮性骨折患者再發(fā)骨折因素及預(yù)防策略的研究進(jìn)展[J].實(shí)用臨床醫(yī)學(xué),2021,22(6):92-96.
[11] HERNLUND E,SVEDBOM A,IVERG?RD M,et al.Osteoporosis in the European Union:medical management,epidemiology and economic burden.A report prepared in collaboration with the International Osteoporosis Foundation(IOF)and the European Federation of Pharmaceutical Industry Associations(EFPIA)[J].Arch Osteoporos,2013,8(1):136.
[12] 張智海,劉忠厚,石少輝,等.中國(guó)大陸地區(qū)以-2.5SD為診斷的骨質(zhì)疏松癥發(fā)病率文獻(xiàn)回顧性研究[J].中國(guó)骨質(zhì)疏松雜志,2015,21(1):1-7.
[13] BANEFELT J,?KESSON K E,SP?NG?US A,et al.Risk of imminent fracture following a previous fracture in a Swedish database study[J].Osteoporos Int,2019,30(3):601-609.
[14] 陳輝,白建中,周功,等.衰弱對(duì)椎體成型術(shù)治療老年骨質(zhì)疏松椎體壓縮性骨折的療效與預(yù)后影響[J].安徽醫(yī)學(xué),2023,44(9):1079-1081.
[15] 張坤,王敏,龍海濤,等.骨質(zhì)疏松性椎體壓縮骨折經(jīng)皮椎體成形術(shù)后再發(fā)骨折預(yù)防措施研究進(jìn)展[J].臨床與病理雜志,2023,43(5):1041-1050.
[16] 林子華,陳歡.中西醫(yī)結(jié)合預(yù)防骨質(zhì)疏松壓縮性骨折經(jīng)皮椎體成形術(shù)后椎體再骨折臨床研究[J].實(shí)用中醫(yī)藥雜志,2019,35(5):547-548.
[17] SCHOENE D,HELLER C,AUNG Y N,et al.A systematic review on the influence of fear of falling on quality of life in older people:is there a role for falls[J].Clin Interv Aging,2019,14:701-719.
[18] 張華果,司文騰,何宇迪,等.老年髖部骨折術(shù)后患者跌倒恐懼心理體驗(yàn)的質(zhì)性研究[J].中華護(hù)理雜志,2021,56(4):527-533.
[19] 祝晟,張嘉.有限元模型在骨質(zhì)疏松性骨折預(yù)測(cè)及評(píng)估中的應(yīng)用[J].中華骨與關(guān)節(jié)外科雜志,2016,9(3):261-265.
[20] GARZA-DE ZAMACONA R,LPEZ-RUBIO A,CARUS-BL?ZQUEZ M J,et al.Risk of refracture according to the FRAX score in patients older than 50 years who suffer a fracture by a low-impact mechanism[J]. Acta Ortop Mex,2022,36(5):292-296.
[21] KANIS J A,JOHANSSON H,HARVEY N C,et al.A brief history of FRAX[J].Arch Osteoporos,2018,13(1):118.
[22] 中華醫(yī)學(xué)會(huì)骨質(zhì)疏松和骨礦鹽疾病分會(huì).原發(fā)性骨質(zhì)疏松癥診療指南(2022)[J].中國(guó)全科醫(yī)學(xué),2023,26(14):1671-1691.
[23] NGUYEN N D,FROST S A,CENTER J R,et al.Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks[J].Osteoporos Int,2008,19(10):1431-1444.
[24] NGUYEN N D,FROST S A,CENTER J R,et al.Development of a nomogram for individualizing hip fracture risk in men and women[J].Osteoporos Int,2007,18(8):1109-1117.
[25] 王洋,曾靜,李春霖,等.骨質(zhì)疏松性骨折風(fēng)險(xiǎn)預(yù)測(cè)工具的研究現(xiàn)狀[J].中國(guó)骨質(zhì)疏松雜志,2021,27(1):143-147.
[26] RUBIN K H,FRIIS-HOLMBERG T,HERMANN A P,et al.Risk assessment tools to identify women with increased risk of osteoporotic fracture:complexity or simplicity?A systematic review[J].J Bone Miner Res,2013,28(8):1701-1717.
[27] 張蕊,劉碩子,段芳芳,等.骨質(zhì)疏松性骨折風(fēng)險(xiǎn)評(píng)估方法研究進(jìn)展[J].中國(guó)慢性病預(yù)防與控制,2022,30(1):62-65.
[28] 鄭苗,魏祺,徐又佳.重視骨質(zhì)疏松性骨折后康復(fù)治療[J].中國(guó)骨質(zhì)疏松雜志,2022,28(4):619-624.
[29] THAN C A,ADRA M,CURTIS T J,et al.The effect of exercise post vertebral augmentation in osteoporotic patients:a systematic review and meta-analysis[J].J Orthop Res,2023,41(12):2703-2712.
[30] 中華醫(yī)學(xué)會(huì)骨科學(xué)分會(huì)骨質(zhì)疏松學(xué)組.骨質(zhì)疏松性骨折診療指南[J].中華骨科雜志,2017,37(1):1-10.
[31] 邱貴興,裴福興,胡偵明,等.中國(guó)骨質(zhì)疏松性骨折診療指南(骨質(zhì)疏松性骨折診斷及治療原則)[J].中華骨與關(guān)節(jié)外科雜志,2015,8(5):371-374.
[32] 張艷梅,馬曉霞,赫繼梅,等.失能老人跌倒的影響因素及長(zhǎng)期照護(hù)服務(wù)需求[J].中國(guó)老年學(xué)雜志,2019,39(17):4355-4357.
[33] WONG R M Y,CHEUNG W H,CHOW S K H,et al.Re-commendations on the post-acute management of the osteoporotic fracture-patients with“very-high”refracture risk[J].J Orthop Translat,2022,37:94-99.
[34] 阮文東,王沛,雪原,等.骨質(zhì)疏松骨折后再骨折的臨床風(fēng)險(xiǎn)因素[J].中華骨科雜志,2011,31(7):789-793.
[35] 朱佩佩,曹玉霖,劉勇,等.骨質(zhì)疏松性骨折與再骨折風(fēng)險(xiǎn)評(píng)估的研究進(jìn)展[J].中華創(chuàng)傷骨科雜志,2019,21(11):1005-1008.
相似文獻(xiàn)/References:
[1]潘雄,劉其順,應(yīng)行,等.中藥聯(lián)合4步康復(fù)鍛煉法對(duì)骨質(zhì)疏松性椎體壓縮
骨折患者生存質(zhì)量的影響[J].中醫(yī)正骨,2015,27(04):65.
[2]宋永枝,陳雙玲.唑來(lái)膦酸靜脈滴注聯(lián)合鮭降鈣素肌肉注射治療
骨質(zhì)疏松性長(zhǎng)骨骨折[J].中醫(yī)正骨,2016,28(01):70.
[3]吳鵬,王博,孔令成,等.強(qiáng)骨飲顆粒聯(lián)合阿侖膦酸鈉維D3片口服在原發(fā)性骨質(zhì)疏松性髖部骨折術(shù)后抗骨質(zhì)疏松治療中的應(yīng)用[J].中醫(yī)正骨,2016,28(05):16.
WU Peng,WANG Bo,KONG Lingcheng,et al.Oral application of Qiangguyin Keli(強(qiáng)骨飲顆粒)and alendronate sodium Vitamin D3 tablets in postoperative anti-osteoporosis treatment in patients with primary osteoporotic hip fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(02):16.
[4]李格,梅偉,劉沛霖,等.骨質(zhì)疏松性椎體壓縮骨折經(jīng)皮椎體成形術(shù)后鄰近椎體再骨折的危險(xiǎn)因素探討[J].中醫(yī)正骨,2016,28(06):18.
LI Ge,MEI Wei,LIU Peilin,et al.Investigation on risk factors for adjacent vertebral refractures after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(02):18.
[5]陳建德,樊曉琦,夏炳江,等.球囊擴(kuò)張部位對(duì)椎體后凸成形術(shù)治療骨質(zhì)疏松性椎體壓縮骨折療效及安全性的影響[J].中醫(yī)正骨,2017,29(02):11.
CHEN Jiande,FAN Xiaoqi,XIA Bingjiang,et al.Influence of balloon dilation position on curative effect and safety of percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(02):11.
[6]史曉林,王健,王博,等.脆性骨折的防治進(jìn)展[J].中醫(yī)正骨,2017,29(05):20.
[7]陳勍,劉鐘,陳文亮,等.股骨近端防旋髓內(nèi)釘固定聯(lián)合口服仙靈骨葆膠囊治療腎陽(yáng)虛型骨質(zhì)疏松性股骨轉(zhuǎn)子間骨折[J].中醫(yī)正骨,2017,29(07):69.
[8]曾武,林曙峰,朱俊峰,等.女性骨質(zhì)疏松性橈骨遠(yuǎn)端骨折鎖定鋼板內(nèi)固定術(shù)后腕關(guān)節(jié)功能恢復(fù)的影響因素分析[J].中醫(yī)正骨,2017,29(08):39.
ZENG Wu,LIN Shufeng,ZHU Junfeng,et al.Analysis of factors influencing wrist function recovery after locking plate internal fixation for treatment of osteoporotic distal radius fractures in female[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(02):39.
[9]丁志清,顏峰,喻燦明,等.椎體后凸成形術(shù)后非典型骨水泥植入綜合征死亡1例[J].中醫(yī)正骨,2017,29(11):76.
[10]俞興,王婷,楊濟(jì)洲,等.經(jīng)皮椎體成形術(shù)和經(jīng)皮椎體后凸成形術(shù)治療Kmmell病的對(duì)比研究[J].中醫(yī)正骨,2018,30(06):23.
YU Xing,WANG Ting,YANG Jizhou,et al.A retrospective trial of percutaneous vertebroplasty versus percutaneous kyphoplasty for treatment of Kmmell's diseases[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(02):23.
[11]于東方,王祥善,張華,等.經(jīng)皮椎體成形術(shù)后手術(shù)椎體再骨折的病因、治療及預(yù)防[J].中醫(yī)正骨,2018,30(10):69.